Agilent Technologies Inc (NYSE: A) stock rose 1.38% after the company posted better than expected results for the first quarter of FY 19 on the back of double-digit growth in both the Agilent CrossLab and Diagnostics and Genomics Group. Earlier this quarter, the company opened a state-of-the-art cell assay development facility in Cork, Ireland. The company also acquired ACEA Biosciences in Q1 adding highly complementary new products to the cell analysis portfolio. The acquisition of ACEA Biosciences increases the relevance and impact the company could have with the customers in this quickly evolving space.

A in the first quarter of FY 19 has reported the adjusted earnings per share of 76 cents, beating the analysts’ estimates for the adjusted earnings per share of 73 cents. The company had reported the adjusted revenue growth of 6 percent to $1.28 billion in the first quarter of FY 19, beating the analysts’ estimates for revenue of $1.27 billion. Reported growth was also 6% as currently negatively impacted growth by 220 basis points and was offset by M&A contributing 210 basis points of growth. Life Sciences & Applied Markets Group grew 1% on a core basis against a very touch compare of 11% growth last year. Pharma, the largest end market delivered 10% core growth. Chemical and energy core growth was 2% against a very strong comparison of 13% last year and was in line with expectations. Instrument sales were effectively flat versus mid-teen gains last year while services and consumables delivered solid mid-single-digit growth. Environmental and forensics was up 10% even as we faced a top low teens compare last year. Double-digit growth in ACG and high single-digit growth LSAG were driven by strength in GCMS, GC, atomic spectroscopy, consumables, and services. Diagnostics and clinical core revenue grew 11% while both academia and government and food were effectively flat.

The Americas region delivered high single-digit core growth as the commercial team continues to execute at a high level while Asia outside of China grew low double digits. Both Europe and China grew low single-digits against a difficult comparison of 9% and 19% respectively.

For the current quarter ending in May, Agilent expects its per-share earnings to range from 70 cents to 72 cents. The company expects revenue to be in the range of $1.25 billion to $1.27 billion for the fiscal second quarter.

Agilent expects full-year earnings 2019 to be in the range of $3.03 to $3.07 per share, and revenue is expected to range from $5.15 billion to $5.19 billion.